184 related articles for article (PubMed ID: 31710123)
1. Benzo[4,5]thieno[2,3-d]pyrimidine phthalimide derivative, one of the rare noncompetitive inhibitors of dipeptidyl peptidase-4.
Tomovic K; Ilic BS; Miljkovic M; Dimov S; Yancheva D; Kojic M; Mavrova AT; Kocic G; Smelcerovic A
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900238. PubMed ID: 31710123
[TBL] [Abstract][Full Text] [Related]
2. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions.
Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and DNase I inhibitory properties of some 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines.
Ts Mavrova A; Dimov S; Yancheva D; Kolarević A; Ilić BS; Kocić G; Šmelcerović A
Bioorg Chem; 2018 Oct; 80():693-705. PubMed ID: 30064080
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
[TBL] [Abstract][Full Text] [Related]
5. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
Khalaf RA; Masalha D; Sabbah D
Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of thiouracil derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Singh D; Gupta M
Chem Biol Drug Des; 2013 Feb; 81(2):257-64. PubMed ID: 23039850
[TBL] [Abstract][Full Text] [Related]
8. Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.
Savateev K; Fedotov V; Butorin I; Eltsov O; Slepukhin P; Ulomsky E; Rusinov V; Litvinov R; Babkov D; Khokhlacheva E; Radaev P; Vassiliev P; Spasov A
Eur J Med Chem; 2020 Jan; 185():111808. PubMed ID: 31683103
[TBL] [Abstract][Full Text] [Related]
9. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
Li S; Xu H; Cui S; Wu F; Zhang Y; Su M; Gong Y; Qiu S; Jiao Q; Qin C; Shan J; Zhang M; Wang J; Yin Q; Xu M; Liu X; Wang R; Zhu L; Li J; Xu Y; Jiang H; Zhao Z; Li J; Li H
J Med Chem; 2016 Jul; 59(14):6772-90. PubMed ID: 27396490
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors.
Khalaf RA; Sabbah D; Al-Shalabi E; Al-Sheikh I; Albadawi G; Abu Sheikha G
Curr Comput Aided Drug Des; 2018; 14(2):142-151. PubMed ID: 29521244
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators.
Fang Y; Zhang S; Wu W; Liu Y; Yang J; Li Y; Li M; Dong H; Jin Y; Liu R; Yang Z
Bioorg Chem; 2020 Jan; 94():103390. PubMed ID: 31662212
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors.
Jiang T; Zhou Y; Zhu J; Chen Z; Sun P; Zhang Q; Wang Z; Shao Q; Jiang X; Li B; Wang H; Zhu W; Shen J
Arch Pharm (Weinheim); 2015 Jun; 348(6):399-407. PubMed ID: 25871012
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
[TBL] [Abstract][Full Text] [Related]
15. Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554.
Maezaki H; Tawada M; Yamashita T; Banno Y; Miyamoto Y; Yamamoto Y; Ikedo K; Kosaka T; Tsubotani S; Tani A; Asakawa T; Suzuki N; Oi S
Bioorg Med Chem Lett; 2017 Aug; 27(15):3565-3571. PubMed ID: 28579121
[TBL] [Abstract][Full Text] [Related]
16. 2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): a potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A.
Nishio Y; Kimura H; Sawada N; Sugaru E; Horiguchi M; Ono M; Furuta Y; Sakai M; Masui Y; Otani M; Hashizuka T; Honda Y; Deguchi J; Nakagawa T; Nakahira H
Bioorg Med Chem; 2011 Sep; 19(18):5490-9. PubMed ID: 21865048
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors.
Tomovic K; Ilic BS; Smelcerovic Z; Miljkovic M; Yancheva D; Kojic M; Mavrova AT; Kocic G; Smelcerovic A
Chem Biol Interact; 2020 Jan; 315():108873. PubMed ID: 31669219
[TBL] [Abstract][Full Text] [Related]
18. Discovery of an Orally Active and Long-Acting DPP-IV Inhibitor through Property-Based Optimization with an in Silico Biotransformation Prediction Tool.
Zeng S; Dou W; Li M; Zhou Y; Guo J; Zhao N; Huang H; Zhou Q; Hu W; Ma Y; Zhao X; Xie H
ChemMedChem; 2020 Aug; 15(16):1608-1617. PubMed ID: 32558296
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors.
Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY
Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502
[TBL] [Abstract][Full Text] [Related]
20. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]